Formulation & Dosage Form: Match Product to Market

Formulation & Dosage Form: Matching the Product to Your Market

Capsule, tablet, or powder? The format you pick changes your cost, your label, and whether the product is even allowed where you sell. Here is the buyer-side read: why it matters, what to look at, and what to ask the factory before you quote.

Independent advisor, paid by the buyer. I run my own biotech company but I am not a factory — and I don’t represent one. This guide is about helping you check, not about selling you anything.


01 Why the formulation starts with the market, not the bottle

A common first move in supplement formulation is to pull a competitor’s bottle off the shelf, copy the label, and ask a factory “make this.” After twenty-plus years inside this supply chain, I keep seeing that move backfire — not because the product is bad, but because the label was built for a different market’s rules. The formula, the dosage form, and the claims that sit on the bottle are all downstream of where you intend to sell. Start there.

The error is understandable. A competitor’s product looks like proof of what works. But “works” and “permitted” are different questions, and they get different answers in different markets. A dosage form that is routine in one region can trigger extra label requirements, extra import steps, or outright restrictions in another. None of that shows up on the competitor’s bottle — it shows up at your border, after you have paid for tooling.

So before you brief a factory, answer the market question first. The rest of this guide is the buyer-side “why, what to look at, and what to ask” that follows from that one decision. If you have not yet pinned down which entity will actually make the goods, pair this read with the Vet Suppliers guide on confirming a real manufacturing entity.

Short answer

Start the formulation from the market you will sell in, not from a competitor’s bottle. The dosage form, the active form, and the excipients all change what your label must say and whether the product is permitted where you sell — so confirm market fit before you ask a factory for a quote.


02 Choosing a dosage form: capsule, tablet, or powder

The dosage form is the first real fork. Capsules, tablets, and powders each carry a different cost profile and a different compliance footprint. Buyers often pick on look or habit; I would pick on the three things a factory cannot decide for you — your fill weight, your market’s format expectations, and your label obligations.

Capsules

Two-piece hard shells (usually gelatin or a vegetable polymer) are the default for many botanical and single-ingredient products. They hide taste, they are easy to fill, and they read as “standard” to most Western buyers. The trade-off is a fill-volume ceiling: a shell only holds so much powder, so a high-strength formula may need two or three capsules per serving. That math quietly raises your per-unit cost and your label’s “servings per container.” For a close look at how the same ingredient behaves in different forms, the berberine sourcing write-up walks through what “99%” actually means on a spec.

Tablets

Tablets compress more material into a smaller unit and are cheap to produce at scale. The catch is the tooling and the compression step, which can be harder on sensitive botanicals and adds excipients (binders, disintegrants, lubricants) that must appear on the label. In some markets a tablet also draws more scrutiny on what holds it together. The OEM private-label cost structure shows how format choices surface later in the cost, not in the headline quote.

Powder and sachets

Powder is the cheapest to produce and the most flexible on dose, but it shifts the burden to the consumer (mixing, taste, measuring) and to your label (serving scoop, net weight, “do not exceed”). Sachets solve the measuring problem and read as premium in some markets, at a higher packing cost.

The table below is the side-by-side I use when a buyer is stuck between formats.

Table 1 — Capsule, tablet, and powder: the cost-and-compliance trade-offs a buyer should weigh before choosing a format
DimensionCapsule (hard shell)TabletPowder / sachet
Production cost at scaleMidLowest for high volumesLowest base; packing cost varies
Strength per unitLimited by shell volumeHigh compression densityFlexible, scoop-based
Excipients that reach the labelShell + few fillersBinders, disintegrants, lubricantsAnti-caking, flavoring if added
Format fit by marketDefault in most Western marketsAccepted; some markets watch additivesVaries; sachets read premium in parts of Asia and EU
Buyer-side watch-outMulti-capsule servings raise unit costTooling + compression can stress botanicalsShifts the measuring burden to the consumer

Source note: cost and fit ranges are framed from industry-common practice and the author’s frontline experience (source B). The specific permit or label rules that apply to each form differ by market and should be confirmed against the destination framework (source A — e.g., FDA 21 CFR Part 101.36 for the US Supplement Facts format; EU Directive 2002/46/EC for permitted dose forms). No factory names, permit numbers, or limit values are stated.


03 What the dosage form actually changes for cost and compliance

Picking a format is not a styling choice. It sets off a chain that ends at your label and your border. The diagram below is the chain I walk buyers through before they quote — and the reason I say the formula starts with the market.

Target market Dosage form Active form & strength Excipients Label & compliance Skip a step and the formula may arrive legal for the wrong market.
The formulation chain starts with the market, not the bottle. The market selects the dosage form; the form sets the room for the active ingredient and the excipients; and those together decide what the label must declare and whether the product clears compliance.

Read the chain left to right. The market selects the format. The format sets how much active ingredient you can fit per unit, which forces a choice of active form. The active form plus the format decide which excipients are needed. The excipients and the active form decide what the label must declare. The label is the compliance gate. Cost and compliance are not two separate columns on a spreadsheet — they are the same chain viewed from two ends. That is why I tell buyers to stop treating “what format do I want” and “is this allowed” as different meetings.


04 Active form and strength: the part a factory can’t guess

A factory can make almost any active form you name. What it cannot do is know which form your market expects, or how your “strength” number was derived. This is where buyers lose money on mismatched quotes — and where a standardized-extract batch COA becomes the document that catches a gap.

Form versus salt

Magnesium oxide and magnesium glycinate are both “magnesium,” but they are different weights, different labels, and different products. If your brief says “500 mg magnesium” without naming the form, three factories will quote three different things, and you will compare apples to oranges while thinking you compared the same formula. Name the exact chemical form. The element weight per unit changes with the salt, and the label declares the form, not just the mineral.

Strength per serving

“Per serving” is a function of your dose form and your serving size. A powder can carry more per scoop than a capsule can per shell. Before you fix a number, know the format it rides in — because the format decides whether the number is even achievable on one unit. I have watched buyers lock a per-serving claim that a capsule could only deliver by asking the customer to swallow four shells at once, which then rewrote the label and the price.

Why it matters (impact): Two quotes that look identical on “active ingredient” can be three different formulas once the form and the serving vehicle are pinned down. The cheapest quote is often the one that quietly changed the form.


05 Excipients: the small print that drives your label

Excipients are the non-active ingredients — the shell, the filler, the flow agent. They are necessary, but each one that survives into the finished product generally has to appear on your label, and some carry flags your market cares about (allergens, dietary status, country-specific warnings). The myths about Chinese factories piece covers the entity side; here the focus is the formula side.

What must appear

Most markets require a full ingredient statement, and “other ingredients” is not a free pass to stay vague. A capsule shell (gelatin or HPMC), a flow agent (magnesium stearate, silica), a filler (microcrystalline cellulose) — all commonly declared. The point for a buyer is not to fear excipients but to know them before they become label surprises. Request the full list in writing as part of the brief.

What can force extra warnings

Some excipients trigger allergen statements or dietary claims. A gelatin shell affects a vegetarian positioning; a soy-derived lecithin affects an allergen line; a colorant can require a warning in one market and be unremarkable in another. These are the quiet label changes that can undercut your brand promise after the product is made and the tooling is paid for.

Scope & boundary (warn): I can tell you which excipient classes commonly reach the label and which commonly trigger flags. I cannot certify your final label as compliant for a given market — that sign-off belongs to the regulator or a qualified label reviewer. The buyer’s job is to surface the excipient list early, before the formula is locked.


06 Confirm the formula is permitted where you sell

This is the step buyers most often skip, then pay for. “Permitted” is not one global answer. The frameworks below are public and worth knowing by name — not so you become a regulator, but so you can ask a factory and a label reviewer the right questions. The FDA vs EFSA claims piece goes deeper on where the same words are allowed and where they are not.

The public frameworks (source A)

  • United States: FDA 21 CFR Part 111 sets the current Good Manufacturing Practice expectations for dietary supplements; FDA 21 CFR Part 101.36 governs the Supplement Facts label format.
  • European Union: Directive 2002/46/EC defines food supplements and the permitted vitamin and mineral forms; EFSA handles the scientific risk assessment; the Novel Food Regulation (EU) 2015/2283 covers ingredients not commonly consumed in the EU before 15 May 1997; nutrition and health claims fall under Regulation (EC) No 1924/2006; general labeling sits under Regulation (EU) No 1169/2011.
  • Other markets: Australia (TGA), the UK, and others each run their own gates. The name of the framework matters less than confirming which one governs your specific product and claims.

I am not a lawyer and this is not legal advice — it is the practical read a buyer-side advisor gives when a client asks “can I sell this here?” The names above are the doors to knock on; the answer behind each door is a conclusion for that regulator or a qualified reviewer.

A pattern I keep seeing (source B): Buyers lock a formula and a label built for Market A, then assume it clears Market B. The dose form, the permitted forms of an ingredient, and the allowed claims rarely line up across borders. The fix is to confirm market fit before tooling, not after a customs hold.

One distinction worth holding onto (source C): a GMP or system certificate shows a manufacturer operates to a standard. It is not, by itself, permission to sell in your market. “Holds a certificate” and “cleared for your market” are different statements, and conflating them is a quiet source of trouble.


07 Questions to settle before you ask for a quote

Put the above into a set of questions you can answer before any quote goes out. This is the “what to ask the factory” section — not a recipe, a screen. The supplier request templates give you the actual language to send; below is the substance to send it about.

  • Are my named target markets fixed before any formula work begins?
  • Is the exact active chemical form named, rather than only the ingredient?
  • Was the dose form chosen on fill weight and market fit, rather than on looks?
  • Have I requested the full excipient list, with allergen and dietary flags?
  • Do I know which frameworks govern compliance in my market?
  • Is label reviewer or regulator sign-off scoped, rather than assumed?

Then ask the factory directly:

  1. “What exact chemical form is this, and what does it weigh per unit of the active element?”
  2. “List every excipient that reaches the finished product.”
  3. “Which markets has this formula actually been cleared for — and by whom?”
  4. “What must the label declare for my target market?”

Read “we have shipped it everywhere” as a screening signal, not proof. The factory-versus-trader case file shows how a smooth answer and a genuine document can still describe an entity that is not the one taking your order — the same caution applies to “our formula is global.”


08 Scope and boundaries (what this guide covers — and what it won’t sign off)

This guide covers the buyer-side framework for formulation and dosage form: why the market comes first, how capsule/tablet/powder trade off on cost and compliance, what the active form and excipients do to your label, and the questions to put to a factory before you quote. That is the “why” and the “what to look for.”

It does not cover the step-by-step “how to write a formula” procedure, the exact request scripts, or the fill-in checklists — those live in the free China Sourcing Pitfall Guide (our lead magnet, delivered by email, kept separate from the site so the site stays a clean reference). And one hard line: I do not certify any formula or supplier as compliant. Whether a specific formulation is permitted in a specific market is a conclusion for a qualified label reviewer and the regulator — not for an article, and not for me by proxy. My job is to help you ask better questions and read the answers clearly. I run my own biotech company in Xianyang, China — botanical extracts and dietary supplements, from raw material to finished product — but I am not a factory and I do not represent one.


Found this useful?

Grab the free China Sourcing Pitfall Guide — the 9-step checklist I send buyers before every order.

Get the free guide

About the author

Luo Gang has spent 20+ years inside China’s health and nutrition industry and 10+ years running his own biotech company (botanical extracts and dietary supplements, from raw material to finished product). He is a native Chinese speaker based in China, works on the buyer’s side of the table, and is not a factory and does not represent one. Paid by buyers, not factories — no commissions.

Sources checked

  • FDA 21 CFR Part 111 (dietary supplement GMP framework) and FDA 21 CFR Part 101.36 (Supplement Facts label format) — public US regulatory frameworks, cited by name only — A
  • EU Directive 2002/46/EC (food supplements; defines “dose form” and lists permitted vitamin/mineral forms), EFSA (risk assessment), Novel Food Regulation (EU) 2015/2283, Regulation (EC) No 1924/2006 (claims), Regulation (EU) No 1169/2011 (labeling) — public EU frameworks, cited by name only — A
  • Capsule/tablet/powder cost-and-fit ranges and the pattern of buyers copying a competitor’s formula then hitting a different market’s rules — based on 20+ years of first-hand sourcing observation, stated as experience, not as a single public clause — B
  • “Permitted in one market, restricted in another” and “certificate ≠ market clearance” as distinctions a buyer must hold — consensus requiring qualification, not a single rule — C
  • No specific factory names, license numbers, or limit values are stated anywhere in this article; where a figure would be needed, the text names the framework and describes the requirement generally — D

FAQ

Q: Should I copy a competitor’s supplement formula for my market? A: Don’t start from a competitor’s bottle. The label was built for that brand’s market and claims, and the same formula can be restricted or require a different label elsewhere. Brief the factory from your own target market, active form, and dose form instead, then confirm compliance before you quote.

Q: Is capsule, tablet, or powder the cheaper supplement format? A: At high volume, tablets are usually the lowest production cost and powder is the cheapest base, but capsule and powder each shift cost elsewhere — capsules raise per-serving unit count when strength is high, and powder moves the measuring burden to the label and the consumer. Pick the format on fill weight and market fit, not on unit price alone.

Q: How do I check whether my supplement formula is allowed in the US and EU? A: Name the frameworks, then confirm fit: in the US, dietary supplements are governed by FDA 21 CFR Part 111 (GMP) and the Supplement Facts label format under 21 CFR Part 101.36; in the EU, Directive 2002/46/EC defines permitted forms, EFSA handles risk assessment, and the Novel Food Regulation (EU) 2015/2283 covers newer ingredients. A GMP certificate shows a standard of operation, not permission to sell — market clearance is a separate question for a label reviewer or regulator.



Related: Vet Suppliers: Real Factory vs Trader · Reading a Supplement COA · Define Your Needs · OEM / Private Label · Manufacturing & QC · Compliance & Certification · Inspection, Payment & Logistics · After-sales & Supply Continuity. Start with the free China Sourcing Pitfall Guide.

Independent advisor · On the buyer’s side.

Luo Gang

Independent China health-product sourcing advisor. Your “China eye” from spec to shipment.

© Luo Gang. All rights reserved. Independent advisor · On the buyer’s side.

Similar Posts